Representative before the EPO

Employment test 51 - 200 employees
Company dna j a kemp
no operation time available
1115.57
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Simon Mark Wright has worked on the following 75 EPO patent applications which have been published in the last five years:

EP11820660

METHOD FOR ENHANCING RED BLOOD CELL QUALITY AND SURVIVAL DURING STORAGE

IPC classification:
A01N 1/02, A61B 19/00, A61M 1/00
Agent:
Simon Mark Wright, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP11778540

EPH RECEPTOR EXPRESSION IN TUMOR STEM CELLS

IPC classification:
A61K 35/00, A61K 38/17
Agent:
Simon Mark Wright, J A Kemp
Agent:
Elisabetta Zaccaro, Notarbartolo & Gervasi SpA
Status:
PATENT GRANTED
EP12707457

TOBACCO INBRED PLANTS NCBEX1F, NCBEX1MS, AND NC EX90

IPC classification:
A01H 5/12, C12N 9/10, C12N 15/82
Applicant:
North Carolina State University
Agent:
Simon Mark Wright, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12708462

TOBACCO INBRED PLANTS ALBEX1F AND ALBEX1MS

IPC classification:
A01H 5/12, A24B 15/10, C12N 15/82
Applicant:
Altria Client Services Inc.
Agent:
Simon Mark Wright, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12727636

EXPANSION OF STEM CELLS IN HOLLOW FIBER BIOREACTORS

IPC classification:
C12M 1/12, C12M 3/06
Agent:
Simon Mark Wright, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12195114

N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors

IPC classification:
A61K 31/18, A61P 9/04, C07D 213/74, C07D 261/10, C07D 263/58, C07D 285/125, C07D 307/82, C07D 333/62
Applicant:
Johns Hopkins University School of Medicine
Agent:
Simon Mark Wright, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12761548

AN ELECTRONIC DATA SHARING DEVICE AND METHOD OF USE

IPC classification:
G06F 21/60
Agent:
Simon Mark Wright, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12195128

N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors

IPC classification:
A61K 31/18, A61P 9/04, C07C 311/48, C07C 317/14, C07C 323/67, C07D 207/36, C07D 213/71, C07D 213/74
Applicant:
Johns Hopkins University School of Medicine
Agent:
Simon Mark Wright, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12840407

A NUCLEIC ACID ASSEMBLY, VECTOR, CELL, METHODS AND KIT THEREOF

IPC classification:
C12N 15/62, C12Q 1/68
Agent:
Simon Mark Wright, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12841014

QUANTIFICATION OF ADAPTIVE IMMUNE CELL GENOMES IN A COMPLEX MIXTURE OF CELLS

IPC classification:
C12N 15/11, C12Q 1/68
Agent:
Boult Wade Tennant Ltd
Agent:
Simon Mark Wright, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12744886

MULTIPARTICULATE L-MENTHOL FORMULATIONS AND RELATED METHODS

IPC classification:
A01N 25/34, A61K 9/50, A61K 31/045, A61K 36/8962
Agent:
Simon Mark Wright, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11855190

METHODS AND KITS FOR TOPICAL APPLICATION, REMOVAL, AND INACTIVATION OF THERAPEUTIC OR COSMETIC TOXIN COMPOSITIONS

IPC classification:
A61K 8/20, A61K 8/29, A61K 8/66, A61K 38/48, A61K 39/02, A61Q 19/00, A61Q 19/08, C12N 1/36
Agent:
Simon Mark Wright, J A Kemp
Status:
The patent has been granted
EP12846133

EXTRACTION OF URANIUM FROM WET-PROCESS PHOSPHORIC ACID

IPC classification:
C01G 43/00, C22B 60/02
Agent:
Simon Mark Wright, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14160382

Compositions for Treating Hearing Loss

IPC classification:
A61K 31/05, A61K 31/07, A61K 31/351, A61K 31/375, A61K 33/06, A61P 27/16
Applicant:
The Regents of the University of Michigan
Agent:
Simon Mark Wright, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13195156

Reagents and Methods for PCR

IPC classification:
C12Q 1/68
Applicant:
Brandeis University
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12806802

METHOD AND SYSTEM FOR LASER SINTERING WITH PRETREATED MATERIAL

IPC classification:
B29C 67/00, C08G 69/26, C08J 3/00
Agent:
Simon Mark Wright, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12856015

DIAGNOSIS OF LYMPHOID MALIGNANCIES AND MINIMAL RESIDUAL DISEASE DETECTION

IPC classification:
C12N 15/11, C12Q 1/68, G01N 33/574
Agent:
Boult Wade Tennant Ltd
Agent:
Simon Mark Wright, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12813423

PYRIDINONE AND PYRIMIDINONE DERIVATIVES AS FACTOR XIA INHIBITORS

IPC classification:
A61K 31/437, A61K 31/519, A61P 9/00, C07D 401/14, C07D 471/04, C07D 487/04
Applicant:
ONO Pharmaceutical Co., Ltd.
Agent:
Simon Mark Wright, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12842230

ANTIGEN PRESENTING CANCER VACCINE

IPC classification:
A61K 38/17, A61K 39/395, A61P 35/00
Agent:
Simon Mark Wright, J A Kemp
Agent:
Mark Charles Green, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION IN PROGRESS
EP11864742

A COMPOSITION FOR TREATING AUTOIMMUNE DISORDERS AND METHODS THEREOF

IPC classification:
A61K 31/351, A61K 31/366, A61K 31/7048, A61K 36/48, A61P 11/00, A61P 17/00, A61P 19/02
Agent:
Simon Mark Wright, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13741160

METHODS AND ASSESSMENT SCALES FOR MEASURING WRINKLE SEVERITY

IPC classification:
A61B 5/107
Agent:
Simon Mark Wright, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13755894

TREATMENT OF BIOMASS

IPC classification:
C02F 3/00, C02F 3/28, C12P 7/00
Agent:
Simon Mark Wright, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13757680

MICRORNAS AND USES THEREOF

IPC classification:
A61K 31/7105, A61K 48/00, A61P 7/12, A61P 31/18, A61P 35/00, C12Q 1/68
Applicant:
University of Western Australia
Agent:
Simon Mark Wright, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13764431

BIOMARKERS

IPC classification:
C07K 7/06, C12Q 1/68, G01N 33/68
Applicant:
Otago Innovation Limited
Agent:
Simon Mark Wright, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13722968

COMPOSITIONS AND METHOD FOR MEASURING AND CALIBRATING AMPLIFICATION BIAS IN MULTIPLEXED PCR REACTIONS

IPC classification:
C12Q 1/68
Agent:
Boult Wade Tennant Ltd
Agent:
Simon Mark Wright, J A Kemp
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13779026

BIOARTIFICIAL FILTRATION ORGAN

IPC classification:
A61L 27/38, A61M 1/14, C12M 3/00, C12N 5/071
Applicant:
The General Hospital Corporation
Agent:
Simon Mark Wright, J A Kemp
Status:
APPLICATION WITHDRAWN
EP13782246

A METHOD OF DETERMINING RNA INTEGRITY

IPC classification:
C12Q 1/68
Agent:
Simon Mark Wright, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13764725

METHOD OF TREATMENT OF WRINKLES USING TOPICAL CHEMODENERVATING AGENTS

IPC classification:
A61F 13/00, A61K 8/64, A61K 39/08, A61P 17/00
Agent:
Simon Mark Wright, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13780960

ONCOLYTIC CLOSTRIDIUM GHONII STRAINS, AND METHODS OF PRODUCTION AND USE

IPC classification:
A61K 39/08, A61P 35/00, C12N 1/20, C12N 1/36
Applicant:
Griffith University
Agent:
Simon Mark Wright, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12745256

PROMOTION OF PLANT GROWTH USING COLLAGEN-BASED GELATIN

IPC classification:
A01C 1/06
Agent:
Simon Mark Wright, J A Kemp
Status:
APPLICATION WITHDRAWN
EP13797528

COMBINATION THERAPY INVOLVING A VASCULAR DISRUPTING AGENT AND AN AGENT WHICH TARGETS HYPOXIA

IPC classification:
A61K 31/343, A61K 31/381, A61K 31/404, A61K 31/44, A61K 31/506, A61K 31/53, A61K 31/661, A61K 31/69, A61P 35/00
Agent:
Simon Mark Wright, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13725462

DINUCELOSIDE POLYPHOSPHATES FOR THE TREATMENT OF PAIN

IPC classification:
A61K 31/7084, A61P 29/02
Agent:
Simon Mark Wright, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12877555

COMPOSITIONS AND METHODS RELATED TO PREVENTION AND TREATMENT OF RABIES INFECTION

IPC classification:
A61K 39/42, A61P 31/14, C07K 16/10, C12N 15/13
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13745211

UNIQUELY TAGGED REARRANGED ADAPTIVE IMMUNE RECEPTOR GENES IN A COMPLEX GENE SET

IPC classification:
C12Q 1/68
Agent:
Boult Wade Tennant Ltd
Agent:
Simon Mark Wright, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13806774

BIOREACTOR CARTRIDGE AND SYSTEM

IPC classification:
C12M 1/18, C12M 3/00
Agent:
Simon Mark Wright, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13883071

ENTERIC COATED MULTIPARTICULATE CONTROLLED RELEASE PEPPERMINT OIL COMPOSITION AND RELATED METHODS

IPC classification:
A61K 9/64
Agent:
Simon Mark Wright, J A Kemp
Status:
PATENT GRANTED
EP13823511

EXTRACTS ISOLATED FROM ELECTROPORATED AMBHIBIAN OOCYTES AND USE THEREOF IN TREATING DISEASES AND DISORDERS

IPC classification:
C12N 5/00, C12N 13/00
Agent:
Simon Mark Wright, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13824904

COMBINATION THERAPY

IPC classification:
A61K 39/395
Agent:
Simon Mark Wright, J A Kemp
Agent:
Russell Thom, Murgitroyd & Company
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13827672

CATHETERS, CATHETER SYSTEMS, AND METHODS FOR PUNCTURING THROUGH A TISSUE STRUCTURE

IPC classification:
A61B 5/05
Applicant:
University of Iowa Research Foundation
Agent:
Simon Mark Wright, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13829340

RAPID METHOD PRODUCTION HIGH PURITY CANCER STEM CELLS AND POPULATION OF HIGH PURITY CANCER STEM CELLS

IPC classification:
A61K 35/12, C12N 5/078, C12N 5/095
Agent:
Simon Mark Wright, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13760080

NANOPARTICLE FORMULATION

IPC classification:
A61K 9/127
Applicant:
Imperial Innovations Limited
Applicant:
Medical Research Council
Agent:
Simon Mark Wright, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13840019

NATURALLY OCCURRING CPG OLIGONUCLEOTIDE COMPOSITIONS AND THERAPEUTIC APPLICATIONS THEREOF

IPC classification:
A61K 31/7088, A61K 35/74, A61K 39/09, A61P 1/16, A61P 35/00, C12N 1/20, C12N 15/117
Agent:
Simon Mark Wright, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13779666

IMMUNOCOMPETENCE ASSESSMENT BY ADAPTIVE IMMUNE RECEPTOR DIVERSITY AND CLONALITY CHARACTERIZATION

IPC classification:
C12Q 1/68
Applicant:
Memorial Sloan Kettering Cancer Center
Agent:
Boult Wade Tennant Ltd
Agent:
Simon Mark Wright, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13859713

METHOD FOR THE DETECTION OF ANALYTES VIA LUMINESCENCE QUENCHING

IPC classification:
C07C 211/54, C07D 333/10, G01N 21/64
Applicant:
The University of Queensland
Agent:
Simon Mark Wright, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP11824177

RADIATION THERAPY FOR TREATING ALZHEIMER'S DISEASE

IPC classification:
A61N 5/10
Agent:
Simon Mark Wright, J A Kemp
Status:
APPLICATION REFUSED
EP14702387

GASTRO-RETENTIVE SUSTAINED-RELEASE ORAL DOSAGE FORM OF A BILE ACID SEQUESTRANT

IPC classification:
A61K 9/00, A61K 9/28, A61K 31/785
Agent:
Simon Mark Wright, J A Kemp
Agent:
Lee Bryan Mullen, Elkington and Fife LLP
Status:
EXAMINATION IN PROGRESS
EP14760978

INDIVIDUALIZED HIGH PURITY HEPATOCELLULAR CARCINOMA STEM CELLS, METHODS AND USE OF THE SAME

IPC classification:
C12N 5/0784, C12N 5/095
Agent:
Simon Mark Wright, J A Kemp
Status:
EXAMINATION REQUESTED
EP14778585

INDIVIDUALIZED HIGH-PURITY GLIOBLASTOMA MULTIFORME STEM CELLS AND METHODS FOR STIMULATING IMMUNE RESPONSE

IPC classification:
A61K 38/17, A61K 38/18, A61K 39/39, A61P 35/00, C07K 16/30
Agent:
Simon Mark Wright, J A Kemp
Status:
EXAMINATION REQUESTED
EP14770283

MINOCYCLINE DERIVATIVES

IPC classification:
A61K 31/65, A61K 47/32, C07C 237/00, C07C 237/06
Agent:
Simon Mark Wright, J A Kemp
Status:
APPLICATION WITHDRAWN
EP14779663

METHOD OF INDUCTION AND PURIFICATION OF A CELL POPULATION RESPONSIBLE FOR VASCULARY MIMICRY AND USE OF THE SAME

IPC classification:
A61K 35/12, A61K 38/18, A61K 38/19, A61P 35/00
Agent:
Simon Mark Wright, J A Kemp
Status:
EXAMINATION REQUESTED
EP14779579

INDIVIDUALIZED HIGH PURITY COLON CARCINOMA STEM CELLS, METHODS AND USE OF THE SAME

IPC classification:
A61K 35/12, A61K 39/39, A61K 39/395, A61P 35/00
Agent:
Simon Mark Wright, J A Kemp
Status:
EXAMINATION REQUESTED
EP15185714

TOPICAL APPLICATION AND TRANSDERMAL DELIVERY OF BOTULINUM TOXINS

IPC classification:
A61K 39/40, A61K 39/42, A61K 47/18, A61K 47/42, A61K 51/00
Agent:
Simon Mark Wright, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14773793

AN EX VIVO HUMAN MULTIPLE MYELOMA CANCER NICHE AND ITS USE AS A MODEL FOR MULTIPLE MYELOMA

IPC classification:
C07K 14/78, C12N 5/09, C12N 5/095, C12Q 1/02
Applicant:
Hackensack University Medical Center
Agent:
Simon Mark Wright, J A Kemp
Status:
EXAMINATION REQUESTED
EP11846559

NOVEL MARKER FOR DETECTION OF BLADDER CANCER AND/OR INFLAMMATORY CONDITIONS OF THE BLADDER

IPC classification:
C12Q 1/68, G01N 33/566, G01N 33/574, G01N 33/68
Agent:
Simon Mark Wright, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13882940

ENTERIC COATED MULTIPARTICULATE COMPOSITION WITH PROTEINACEOUS SUBCOAT

IPC classification:
A61P 1/00, A61P 1/04, A61P 1/14
Agent:
Simon Mark Wright, J A Kemp
Status:
EXAMINATION REQUESTED
EP14795260

STRUCTURE-BASED PEPTIDE INHIBITORS OF P53 AGGREGATION AS A NEW APPROACH TO CANCER THERAPEUTICS

IPC classification:
A61K 38/08, A61P 35/00, C07K 7/06, C12N 15/63
Applicant:
The Regents of the University of California
Agent:
Simon Mark Wright, J A Kemp
Status:
EXAMINATION REQUESTED
EP15187435

PROLIFERATION SIGNATURE AND PROGNOSIS FOR GASTROINTESTINAL CANCER

IPC classification:
C12Q 1/68
Agent:
Simon Mark Wright, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11776958

PHARMACEUTICAL FORMULATION FOR HISTONE DEACETYLASE INHIBITORS

IPC classification:
A61K 9/06, A61K 31/165, A61K 47/02, A61K 47/10, A61K 47/12, A61K 47/14, A61K 47/38, A61P 17/00, A61P 35/00
Agent:
Simon Mark Wright, J A Kemp
Agent:
Michael D. Snodin, Potter Clarkson LLP
Status:
EXAMINATION IN PROGRESS
EP15181440

KITS FOR ANALYZING SINGLE-STRANDED NUCLEIC ACID SEQUENCES

IPC classification:
C12Q 1/68, G01N 21/76, G01N 33/48
Applicant:
Brandeis University
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12195118

N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors

IPC classification:
A61K 31/18, A61P 9/04, C07C 311/48, C07C 317/14, C07C 323/67, C07D 213/74, C07D 261/10, C07D 263/58, C07D 285/125, C07D 295/096, C07D 307/82, C07D 309/12, C07D 333/62
Applicant:
Johns Hopkins University School of Medicine
Applicant:
Johns Hopkins University
Agent:
Simon Mark Wright, J A Kemp
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11721840

METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF CANCER RESISTANT TO ANAPLASTIC LYMPHOMA KINASE (ALK) KINASE INHIBITORS

IPC classification:
A01K 67/027, C07K 14/71, C07K 16/30, C12N 1/15, C12N 1/21, C12N 5/10, C12Q 1/48, C12Q 1/68, G01N 33/53, G01N 33/574
Agent:
Simon Mark Wright, J A Kemp
Status:
PATENT GRANTED
EP14766572

MODIFIED EPSTEIN-BARR VIRUS DNA POLYMERASE AND METHODS FOR ISOTHERMAL DNA AMPLIFICATION

IPC classification:
C07K 14/05, C12N 9/12, C12N 15/10
Applicant:
University of Connecticut
Agent:
Simon Mark Wright, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14766370

ANTISENSE-INDUCED EXON2 INCLUSION IN ACID ALPHA-GLUCOSIDASE

IPC classification:
A61K 31/712, A61K 31/7125, C07H 21/00, C12N 15/113
Applicant:
Murdoch University
Agent:
Simon Mark Wright, J A Kemp
Status:
EXAMINATION REQUESTED
EP14849674

HIGHLY POTENT GLUCOCORTICOIDS

IPC classification:
A61K 31/58, A61P 5/44, A61P 11/06, C07J 71/00
Agent:
Simon Mark Wright, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14799259

METHODS AND SYSTEMS FOR INHIBITING FOREIGN-BODY RESPONSES IN DIABETIC PATIENTS

IPC classification:
A61M 5/142, A61M 5/158
Applicant:
Medtronic MiniMed Inc
Agent:
Simon Mark Wright, J A Kemp
Status:
EXAMINATION REQUESTED
EP12195124

N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors

IPC classification:
A61K 31/18, A61P 9/04, C07C 311/48, C07C 317/14, C07C 323/67
Applicant:
Johns Hopkins University School of Medicine
Applicant:
Johns Hopkins University
Agent:
Simon Mark Wright, J A Kemp
Status:
PATENT GRANTED
EP14863459

TRIAGING OF PATIENTS HAVING ASYMPTOMATIC HEMATURIA USING GENOTYPIC AND PHENOTYPIC BIOMARKERS

IPC classification:
G01N 33/574
Agent:
Simon Mark Wright, J A Kemp
Status:
EXAMINATION REQUESTED
EP14806368

COMPOSITIONS

IPC classification:
A61K 31/7084, A61K 45/06, A61P 23/00, A61P 29/00
Agent:
Simon Mark Wright, J A Kemp
Status:
EXAMINATION REQUESTED
EP14806369

COMPOSITIONS

IPC classification:
A61K 31/7084, A61K 45/06, A61P 25/08
Agent:
Simon Mark Wright, J A Kemp
Status:
EXAMINATION REQUESTED
EP14867253

PEPTIDES FOR DIAGNOSING LYME DISEASE

IPC classification:
C07K 14/20, G01N 33/569, G01N 33/58
Agent:
Simon Mark Wright, J A Kemp
Status:
EXAMINATION REQUESTED
EP16180406

METHOD OF TREATMENT OF WRINKLES USING TOPICAL CHEMODENERVATING AGENTS

IPC classification:
A61F 13/00, A61K 8/02, A61K 8/64, A61K 8/99, A61K 39/08, A61P 17/00, A61Q 19/08
Agent:
Simon Mark Wright, J A Kemp
Status:
APPLICATION PUBLISHED
EP16165849

AROMATIC-CATIONIC PEPTIDES AND USES OF SAME

IPC classification:
B09C 1/10, C07K 5/09, C12Q 1/44, G01N 27/327, H01L 51/00
Applicant:
Stealth Peptides International, Inc.
Applicant:
Cornell University
Agent:
Simon Mark Wright, J A Kemp
Status:
Request for examination was made
EP15841946

ANTI-EGFR ANTIBODY AND USES OF SAME

IPC classification:
A61K 39/395
Agent:
Simon Mark Wright, J A Kemp
Status:
EXAMINATION REQUESTED
EP15759071

REAL-TIME AND CONTINUOUS DETERMINATION OF EXCESS POST-EXERCISE OXYGEN CONSUMPTION AND THE ESTIMATION OF BLOOD LACTATE

IPC classification:
A61B 5/02, A61B 5/024, A61B 5/1455
Agent:
Simon Mark Wright, J A Kemp
Status:
EXAMINATION REQUESTED
EP16175320

METHODS AND COMPOSITIONS RELATING TO FUSIONS OF ALK FOR DIAGNOSING AND TREATING CANCER

IPC classification:
C08B 3/00, C12P 19/34, C12Q 1/68
Agent:
Simon Mark Wright, J A Kemp
Status:
APPLICATION PUBLISHED

Please Sign in to use this feature